NLM Logo

LLA-IV-AR protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
LLA-IV-AR protocol
Unique ID
C054969
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C054969
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Cytarabine
Methotrexate
Prednisone
Teniposide
Vincristine
Frequency
1
Note
chemotherapy protocol consisting of above 6 cpds
Source
An Esp Pediatr 1987;27(5):331
Date of Entry
1988/03/25
Revision Date
2000/11/30
LLA-IV-AR protocol Preferred
page delivered in 0.006s